Mutations directly associated with the peroxisomal fatty acid α-oxidation pathway are extremely rare, with an estimated 1 in 106 incidence of Refsum disease in the UK [37], while only a handful of AMACR deficient patients have been reported in the literature. This evidence concerns the gene AMACR and Refsum disease.